Flat-rate pricing No commitment required · Cancel anytime Prescription included · Online questionnaire, no video call · Dose adjustment supported Multiple pharmacy options · Third-party tested Free shipping · Supplies included · Discreet packaging Money-back guarantee Tirzepatide, Semaglutide · Zepbound, Wegovy, Foundayo Available in all 50 states Pricing varies by pharmacy Auto-renewing plans Other fees may apply Mixed additive-free optionsProvider Plans Injectable Plan Tirzepatide Monthly
Dose Your Supply Your Price Your Supply Avg/mo Your Value 2.5mg/wk 10mg/mo $349.00 10mg $349 $34.90/mg 5.0mg/wk 20mg/mo $349.00 20mg $349 $17.45/mg 7.5mg/wk 30mg/mo $349.00 30mg $349 $11.63/mg 10.0mg/wk 40mg/mo $349.00 40mg $349 $8.72/mg 12.5mg/wk 50mg/mo $349.00 50mg $349 $6.98/mg 15.0mg/wk 60mg/mo $349.00 60mg $349 $5.82/mg
Zepbound Pen Tirzepatide Monthly Brand
Dose Your Supply Your Price Your Supply Avg/mo Your Value 2.5mg/wk 10mg/mo $349.00 10mg $349 $34.90/mg 5.0mg/wk 20mg/mo $349.00 20mg $349 $17.45/mg 7.5mg/wk 30mg/mo $349.00 30mg $349 $11.63/mg 10.0mg/wk 40mg/mo $349.00 40mg $349 $8.72/mg 12.5mg/wk 50mg/mo $349.00 50mg $349 $6.98/mg 15.0mg/wk 60mg/mo $349.00 60mg $349 $5.82/mg Consultation fee not included
Provider Details In-House Rx Dose Adjustments By Appointment
Prescription Included Yes
Telehealth Included Yes
Online-Only Option Yes
Skip Labs Not Disclosed
Credit Money-Back Guarantee
Insurance Accepted No
HSA/FSA Accepted Yes
Financing Available Yes
Trustpilot 4.7 150,000+ Patients
LegitScript Certified Yes
HIPAA Compliant Yes
Mobile App Not Disclosed
Supplies Included Cold-Packed
Free Shipping Yes
Expedited Shipping No
Discreet Packaging Yes
Formats: Injection · Oral Sublingual Brands: Foundayo · Wegovy Pen · +1
Offers Tirzepatide Yes
Offers Semaglutide Yes
Offers Brand Yes
Other Treatments Yes
Phone Not Disclosed
Address Not Disclosed
Provider Notes Compliance The FDA resolved the semaglutide shortage on April 22, 2025. Compounding is permitted only for individually identified patients when a prescribing practitioner determines that the compounded preparation produces a significant difference for their patient compared to the FDA-approved product.